Ebola outbreak: New vaccine trials to be fast-tracked in UK, USA and Africa

Trials could begin as early as the next few weeks if all goes to plan

Health Correspondent

A new Ebola vaccine aimed at preventing the disease that has claimed the lives of more than 1,200 people in West Africa is to be tested in fast-tracked safety trials in the United Kingdom, Africa and the United States.

Codeveloped by the National Institutes of Health (NIH) in the United States and the pharmaceutical multinational GlaxoSmithKline, human trials of the vaccine will be accelerated due to the current epidemic, which the World Health Organisation (WHO) recently identified as a public health emergency of “international concern”.

If ethical and regulatory approval is given, the UK research teams involved in the international consortium conducting the trial could begin their work within the next few weeks. Volunteers in the UK could be given the candidate vaccine as early as mid-September.

A £2.8 million grant from the Wellcome Trust, the Department for International Development (DFID) and the Medical Research Council will allow a team from the Jenner Institute at the University of Oxford to start the vaccine tests. Parallel trials will also start in the US.

The Oxford team will be led by Professor Adrian Hill. He said: “the tragic events unfolding in Africa demand an urgent response. In recent years, similar investigational vaccines have safely immunised infants and adults against a range of diseases including malaria, HIV and Hepatitis C. We, and all our partners on this project, are optimistic that this candidate vaccine may prove useful against Ebola.”

In Africa, vaccine trials will be conducted by the MRC in the Gambia. Trials will also take place in neighbouring Mali.


The WHO’s increasing concern about the level of the Ebola epidemic in West Africa, and the need for an emergency immunisation programme to begin as soon as possible, has meant that GSK will begin manufacturing almost 10,000 additional does of the vaccine while the clinical trials are still in progress.

If the trials prove to be safe and effective, stocks of the new vaccine could be made available to the United Nations by GSK, with a fast-tracked immunisation programme following almost immediately.

The new vaccine has been developed to combat the Zaire species of Ebola. This is the variant of the disease that is currently affecting West Africa. Because of its biological construction and the way it generates a protective immune response, it cannot cause a person who is vaccinated to become infected with Ebola.

Pre-clinical research has indicated the new vaccine provided “promising protection” to non-human primates which have been exposed to Ebola without showing any significant effects.

The initial results from the Oxford study – involving 60 volunteers - will be critical. If no adverse reactions are found in the UK study, further trials will be extended to a 40 volunteers at the MRC Unit in the Gambia.

A second African study, conducted by researchers at the University of Maryland’s Vaccine Development Programme in Mali , is scheduled to begin in the state capital Bamako.

Dr Jeremy Farrar, director of the Wellcome Trust, said: “This epidemic has shown how difficult it can be to control Ebola. How useful drugs and vaccines might be in complementing existing public health interventions can only be assessed in epidemics. The initial safety work we're announcing today with our international partners will hopefully make that possible during this crisis and for inevitable future epidemics.”

Professor Umberto D'Alessandro, director of the MRC Unit in the Gambia, said: “Thanks to the long-term collaboration between the MRC and the Gambian Government’s Ministry of Health, we have the proven capacity and expertise to carry out trials to the highest quality standards, including trials for vaccines similar to this one. This trial won’t benefit immediately those currently at risk but we hope that in a not too distant future we may be able to protect people against Ebola.”

The UK's International Development Secretary Justine Greening said: “We are cofunding these important clinical trials to find a safe vaccine for Ebola, as well as providing critical care on the ground. Britain is a world leader in medical research and mobilising our unique strengths to find a vaccine could be pivotal to containing Ebola and preventing future outbreaks.”

Life and Style
ebookNow available in paperback
ebookA delicious collection of 50 meaty main courses
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Recruitment Genius: SAGE Bookkeeper & PA to Directors

    £18000 - £24000 per annum: Recruitment Genius: An exciting opportunity has ari...

    Recruitment Genius: Online Sales and Customer Services Executive

    £15000 - £18000 per annum: Recruitment Genius: An On-line Sales & Customer Ser...

    Recruitment Genius: Accounts Assistant - Fixed Term Contract - 6 Months

    £15000 per annum: Recruitment Genius: One of the largest hospitality companies...

    Recruitment Genius: Electricians - Fixed Wire Testing

    £28000 - £32000 per annum: Recruitment Genius: As a result of significant cont...

    Day In a Page

    Seifeddine Rezgui: What motivated a shy student to kill 38 holidaymakers in Tunisia?

    Making of a killer

    What motivated a shy student to kill 38 holidaymakers in Tunisia?
    UK Heatwave: Temperatures on the tube are going to exceed the legal limit for transporting cattle

    Just when you thought your commute couldn't get any worse...

    Heatwave will see temperatures on the Tube exceed legal limit for transporting cattle
    Exclusive - The Real Stories of Migrant Britain: Swapping Bucharest for London

    The Real Stories of Migrant Britain

    Meet the man who swapped Romania for the UK in a bid to provide for his family, only to discover that the home he left behind wasn't quite what it seemed
    Cheaper energy on the way, but it's not all sunshine and rainbows

    Cheaper energy on the way, but it's not all sunshine and rainbows

    Solar power will help bring down electricity prices over the next five years, according to a new report. But it’s cheap imports of ‘dirty power’ that will lower them the most
    Katy Perry prevented from buying California convent for $14.5m after nuns sell to local businesswoman instead

    No grace of God for Katy Perry as sisters act to stop her buying convent

    Archdiocese sues nuns who turned down star’s $14.5m because they don’t approve of her
    Ajmer: The ancient Indian metropolis chosen to be a 'smart city' where residents would just be happy to have power and running water

    Residents just want water and power in a city chosen to be a ‘smart’ metropolis

    The Indian Government has launched an ambitious plan to transform 100 of its crumbling cities
    Michael Fassbender in 'Macbeth': The Scottish play on film, from Welles to Cheggers

    Something wicked?

    Films of Macbeth don’t always end well - just ask Orson Welles... and Keith Chegwin
    10 best sun creams for body

    10 best sun creams for body

    Make sure you’re protected from head to toe in the heatwave
    Wimbledon 2015: Nick Bollettieri - Milos Raonic has ability to get to the top but he must learn to handle pressure in big games

    Nick Bollettieri's Wimbledon files

    Milos Raonic has ability to get to the top but he must learn to handle pressure in big games
    Women's World Cup 2015: How England's semi-final success could do wonders for both sexes

    There is more than a shiny trophy to be won by England’s World Cup women

    The success of the decidedly non-famous females wearing the Three Lions could do wonders for a ‘man’s game’ riddled with cynicism and greed
    How to stop an asteroid hitting Earth: Would people co-operate to face down a global peril?

    How to stop an asteroid hitting Earth

    Would people cooperate to face a global peril?
    Just one day to find €1.6bn: Greece edges nearer euro exit

    One day to find €1.6bn

    Greece is edging inexorably towards an exit from the euro
    New 'Iron Man' augmented reality technology could help surgeons and firefighters, say scientists

    'Iron Man' augmented reality technology could become reality

    Holographic projections would provide extra information on objects in a person's visual field in real time
    Sugary drinks 'are killing 184,000 adults around the world every year'

    Sugary drinks are killing 184,000 adults around the world every year

    The drinks that should be eliminated from people's diets
    Pride of Place: Historians map out untold LGBT histories of locations throughout UK

    Historians map out untold LGBT histories

    Public are being asked to help improve the map